We are an university hospital spin-off focusing on AI-enabled cancer diagnostics and currently under UC Berkeley SkyDeck accelerator program.
Our lead product is AHEAD-flow platform, a machine learning based, fully automated analysis tool for clinical cytometry exams on blood cancer patients that is 100 times faster than current method.
We are one of the panelists of the AI diagnostics for disease detection section in track one.
Currently, we are raising 2.5M USD to have our leukemia monitoring module of the AHEAD-flow platform cleared by FDA.
Our lead product is AHEAD-flow platform, a machine learning based, fully automated analysis tool for clinical cytometry exams on blood cancer patients that is 100 times faster than current method.
We are one of the panelists of the AI diagnostics for disease detection section in track one.
Currently, we are raising 2.5M USD to have our leukemia monitoring module of the AHEAD-flow platform cleared by FDA.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Delaware
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Medical Devices
Lead Product in Development:
AHEAD-flow platform
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
